
Written by:

Medically Reviewed by:
Last Updated:
May 15th, 2026
Heroin withdrawal and detox
Heroin detox is the first and, for many people, the most daunting stage of the journey towards recovery. However, without professional support, heroin detox carries serious risks. Having the right clinical care means heroin detox can be managed safely, humanely, and with significantly reduced discomfort.
Having a comprehensive, evidence-informed overview of heroin detox: what it involves, why it is medically complex, what to expect during the withdrawal process, how it is treated, and how it fits into a broader programme of heroin addiction recovery is vital to alleviating any concerns you may have regarding detox.
What is Heroin Detox?
Heroin detox refers to the process of safely discontinuing heroin use while the body eliminates the opioidate and adjusts to its absence by re-establishing its natural neurochemical balance. Because heroin produces rapid and profound physical dependence, stopping abruptly without medical support, triggers significant withdrawal syndromes that, while rarely fatal in otherwise healthy individuals, is intensely uncomfortable and carries real medical risks including dehydration, cardiovascular stress, and severe psychological crisis.
Detox should always be understood as the beginning of treatment, not the totality of it. Clearing heroin from the body does not in itself address the neurobiological, psychological, and social drivers of heroin addiction. Without a structured programme of therapy and aftercare following detox, the risk of relapse is very high. Medically assisted detox integrated into a comprehensive treatment programme is the best way to produce substantially better long-term outcomes than detox alone.
Why Heroin Detox Is So Challenging
Unlike some other substances, heroin produces both intense physical dependence and severe psychological dependence concurrently. The complexity of heroin detox arises from several interconnected factors:
The Symptoms and Timeline of Heroin Withdrawal
Heroin withdrawal follows a broadly predictable trajectory, although the timing and severity are influenced by individual factors including the duration and quantity of use, the method of administration, physical health, and whether other substances are also involved.
Common heroin withdrawal symptoms include:
- Intense cravings for the drug: Strong, persistent urges to use heroin again are often one of the earliest and most difficult symptoms. These cravings are driven by both physical dependence and psychological habits.
- Irritability and mood changes: Emotional regulation is often disrupted, leading to frustration, agitation, and heightened sensitivity to stress or everyday triggers.
- Anxiety and depression: Many individuals experience increased anxiety, low mood, or a sense of emotional emptiness as brain chemistry begins to rebalance.
- Nausea and vomiting: The digestive system is commonly affected, leading to stomach discomfort, nausea, and in some cases vomiting and diarrhoea.
- Insomnia and sleep disturbances: Difficulty falling or staying asleep is very common, often combined with restless or broken sleep patterns.
- Fatigue and exhaustion: Despite poor sleep, individuals often feel physically drained and lacking in energy as the body works to stabilise.
- Changes in appetite: Appetite may fluctuate significantly, with some people experiencing a loss of interest in food, while others feel increased hunger during recovery.
- Restlessness and agitation: A sense of internal unease or inability to relax is common, often making it difficult to sit still or feel comfortable.
- Tremors and shakiness: Mild shaking or trembling can occur as the nervous system becomes overstimulated during withdrawal.
- Muscle aches and body pain: Generalised aches, joint stiffness, and flu-like discomfort are frequently reported as the body adjusts to the absence of opioids.
The table below provides a comprehensive overview of the withdrawal timeline and the clinical significance of each phase:
| Phase | Typical Symptoms | Added Notes |
|---|---|---|
| 0–12 hours | Anxiety, restlessness, cravings, yawning, runny nose | Onset varies with last dose and frequency of use. Short-acting opioids produce earlier onset. |
| 12–36 hours | Muscle aches, sweating, chills, nausea, insomnia, agitation | Peak discomfort typically begins. Vomiting and diarrhoea often emerge. |
| 36–72 hours | Peak withdrawal: severe muscle cramps, vomiting, diarrhoea, tachycardia, hypertension, profuse sweating | The most medically critical window. Dehydration and electrolyte imbalance are primary risks requiring clinical monitoring. |
| 3–7 days | Gradual subsidence of acute symptoms. Persistent insomnia, fatigue, anxiety | Physical symptoms begin to ease. Psychological distress often intensifies as medication reduces. |
| 1–4 weeks | Residual insomnia, mood instability, cravings, low energy, anhedonia | Post-Acute Withdrawal Syndrome (PAWS) may persist. Relapse risk is high in this phase. |
| Weeks–months | Intermittent cravings, depression, heightened stress sensitivity, cognitive fog | PAWS symptoms can continue for weeks to months. Ongoing psychological support and relapse prevention are essential. |
Post-Acute Withdrawal Syndrome (PAWS)
Beyond the acute withdrawal phase, many people recovering from heroin use experience Post-Acute Withdrawal Syndrome (PAWS). This refers to a cluster of persistent or recurring symptoms caused by the gradual rebalancing of the brain’s opioid and stress-response systems.
- Persistent insomnia and disturbed sleep: Often one of the most distressing and enduring symptoms, contributing significantly to relapse risk.
- Anhedonia: The inability to experience pleasure from activities that were previously enjoyable, reflecting ongoing dopamine system dysfunction.
- Cognitive difficulties: Impaired memory, concentration, and decision-making can persist for weeks to months.
- Emotional dysregulation: Heightened emotional reactivity, mood swings, irritability, and episodes of depression or anxiety.
- Intermittent cravings: Drug cravings that can be triggered by stress, cues, or seemingly without cause, reflecting sensitised reward memory circuits.
Understanding PAWS is critical to relapse prevention. Many people relapse, not during the peak of acute withdrawal, but weeks or even months into recovery, when visible physical symptoms have subsided but underlying neurobiological healing is still ongoing. Sustained therapeutic support and structured aftercare, which Banbury Lodge can provide, is essential during this phase.
Medications Used in Heroin Detox
Modern heroin detox is a structured, evidence-based clinical process, far removed from the unsupported “cold turkey” approaches of the past. Medical management can significantly reduce withdrawal severity, lower risk, and support individuals through one of the most physically and psychologically demanding stages of recovery.
Medications used in heroin detox fall into two main categories: opioid substitution therapies, which act on opioid receptors to stabilise withdrawal, and supportive medications, which target specific symptoms such as anxiety, pain, nausea, and insomnia.
Examples of the most commonly used medications in UK clinical practice are:
Methadone: A long-acting opioid used to prevent withdrawal and reduce cravings. It is typically administered under daily oversight and used for stabilisation or gradual tapering.
Buprenorphine (Subutex): A partial opioid agonist that reduces withdrawal symptoms with a ceiling effect on respiratory depression, lowering overdose risk. It must be carefully initiated to avoid precipitated withdrawal.
Buprenorphine/Naloxone (Suboxone): A combination of buprenorphine and naloxone. The naloxone component reduces the risk of misuse, particularly via injection. It is widely used due to its safety profile.
Naltrexone: An opioid antagonist, is used after detox to block the effects of opioids entirely and support relapse prevention. It must only be started once all opioids have been fully cleared from the system.
Lofexidine (BritLofex) & Clonidine: Non-opioid medications that reduce autonomic withdrawal symptoms such as sweating, anxiety, rapid heart rate, and agitation. Often used where opioid-based treatments are not suitable.
Diazepam: Used short-term for severe anxiety, muscle spasms, or acute insomnia during withdrawal. Prescribing is tightly controlled due to its own dependence risk.
Opioid Substitution Therapy (OST)
Opioid substitution therapy using methadone or buprenorphine is one of the most effective treatments for opioid dependence. Opioid Substitution Therapy can:
- Reduces illicit heroin use and associated criminal activity
- Significantly lowers overdose risk and all-cause mortality
- Improves physical health outcomes, including reduced transmission of blood-borne viruses
- Increases retention in treatment, a key predictor of long-term recovery
- Provides stability that enables psychological and behavioural therapy to be effective
In residential detox settings, OST is delivered through a controlled tapering process, allowing the body to adjust gradually rather than experiencing abrupt cessation. This approach is safer, more tolerable, and clinically superior to unmanaged withdrawal.
Alongside substitution therapies, additional medications are used to manage symptoms and maintain physical stability:
- Anti-emetics (e.g. ondansetron, metoclopramide) for nausea and vomiting
- Antidiarrhoeals (e.g. loperamide) for gastrointestinal symptoms
- NSAIDs and paracetamol for muscle and joint pain
- Short-term sleep support for severe insomnia
- Fluids and electrolyte replacement where dehydration is present
- Vitamin and nutritional supplementation, particularly thiamine (B1), folate, and vitamin D
While these medications significantly improve safety and comfort during detox, they must be used within a strictly controlled framework. Several, including benzodiazepines and opioid substitution medications, carry their own dependence risk if misused or taken without monitoring.
For this reason, heroin detox should never be attempted independently. Effective treatment requires structured prescribing, continuous monitoring, and integration into a wider recovery programme that addresses both physical dependence and the psychological drivers of heroin addiction.
Types of Heroin Detox Setting
Heroin detox can be undertaken in different clinical environments, and the most appropriate setting depends on the individual’s history, physical health, social circumstances, and the degree of risk involved.
Residential (Inpatient) Detox
Residential detox, conducted in a specialist treatment centre, is generally regarded as the gold standard for heroin detox, particularly for those with long-term or heavy patterns of use. The key advantages of residential detox include:
- Consistent observation: vital for safe management of withdrawal and immediate response to complications
- Complete removal from using environments: eliminating access to heroin and heroin-related cues during the most vulnerable phase
- Structured therapeutic engagement: psychological support, group therapy, and individual counselling can begin in parallel with detox
- Nutritional support and restoration: supervised meals and supplementation to begin addressing the physical depletion of addiction
- Peer support: the community environment of residential treatment is itself a powerful therapeutic factor
Community (Outpatient) Detox
Community detox involves withdrawal while the individual continues to live at home, with regular appointments at a drug treatment service or GP. While community detox may be appropriate for individuals with shorter histories of use, lower levels of dependence, and robust social support, it carries significantly higher risks in the context of heroin addiction:
- Continued access to heroin and drug-using peers makes relapse far more likely
- The absence of constant medical oversight means that complications may not be identified promptly
- Stress from domestic or social environments can overwhelm withdrawal management
- Compliance with prescribed medications is less assured outside a supervised environment
For the majority of people with established heroin dependence, residential detox offers a substantially safer and more effective environment in which the process can be completed successfully.
The Risks of Detoxing Without Medical Support
Attempting to detox from heroin without medical support is not only significantly more distressing than managed detox but carries genuine and serious risks:
- Severe dehydration and electrolyte imbalance: Profuse sweating, vomiting, and diarrhoea during withdrawal can lead to dangerous dehydration, particularly in those who are already physically compromised. Severe electrolyte disturbance can trigger cardiac arrhythmias.
- Cardiovascular events: Autonomic rebound during withdrawal causes significant elevations in heart rate and blood pressure. In individuals with pre-existing cardiovascular conditions, this can precipitate serious cardiac events.
- Psychiatric crisis and suicide risk: Unmanaged heroin withdrawal is associated with severe depression, profound hopelessness, and an elevated risk of suicidal ideation and self-harm. Without psychological support, individuals may be at serious risk.
- Seizures: While not a universal feature of opioid withdrawal, individuals who are also dependent on alcohol or benzodiazepines face a very high risk of life-threatening seizures if all substances are withdrawn simultaneously without medical supervision.
- Rapid tolerance loss and overdose risk: Tolerance to heroin falls dramatically within days of cessation. Individuals who relapse following an unsupported detox attempt are at very high risk of fatal overdose if they return to their previous dose, as their body can no longer tolerate the same amount.
Unsupported heroin detox is extremely dangerous, unnecessary, and dramatically less likely to result in sustained recovery.
Heroin Detox and Dual Diagnosis
A substantial proportion of individuals presenting for heroin detox have co-occurring mental health conditions, with research consistently demonstrating that the majority of people with heroin addiction have at least one comorbid psychiatric condition, most commonly depression, anxiety disorders, PTSD, borderline personality disorder, or psychotic disorders.
Effective heroin detox in this context requires more than simply managing physical withdrawal. The detox process itself can precipitate or significantly exacerbate psychiatric symptoms, as the pharmacological suppression of distress that heroin has been providing is removed. High-quality residential detox programmes provide:
- Comprehensive psychiatric assessment: Conducted before and during detox to identify pre-existing conditions and monitor for emerging psychiatric symptoms
- Trauma-informed care: Recognising that many individuals in heroin addiction carry significant trauma histories, and that detox can bring suppressed traumatic material to the surface
- Crisis support: Access to mental health professionals when psychological distress becomes acute during the withdrawal process
The integration of mental health and substance misuse treatment within the same programme, rather than sequential treatment, is associated with significantly better outcomes in people with dual diagnosis.
What Happens After Detox?
Completing heroin detox is a significant step, however, it is not the end of treatment. The brain’s recovery from heroin dependence is a process measured in months, not days, and the neurobiological, psychological, and social vulnerabilities that contributed to addiction do not resolve with opioid clearance alone. Without structured support following detox, relapse rates are extremely high.
Effective post-detox treatment typically includes:
- Residential rehabilitation: A structured period in a residential therapeutic community following detox, combining individual psychotherapy, group therapy, and practical life-skills work is associated with the best long-term recovery outcomes. It provides the time, space, and clinical expertise needed to address the underlying drivers of heroin addiction.
- Evidence-based psychological therapies: Cognitive Behavioural Therapy (CBT), Dialectical Behaviour Therapy (DBT), and trauma-focused therapies each have a robust evidence base in heroin addiction recovery and relapse prevention.
- Relapse prevention planning: Identifying personal triggers, developing coping strategies, and creating a concrete, personalised relapse prevention plan are essential before leaving a residential programme.
- Structured aftercare and support networks: Ongoing group therapy, key-working, mutual aid groups (such as Narcotics Anonymous), and family support provide the continuing community and accountability that sustain recovery beyond formal treatment.
The weeks and months following acute heroin detox is a particularly important and vulnerable window. Sustained engagement with the right support and a clear structure in daily life are the most powerful protective factors against relapse during this time.
Naloxone: A Critical Harm-Reduction Tool
For anyone in the process of reducing or stopping heroin use (or for those around them) naloxone is a potentially life-saving medication that reverses opioid overdose rapidly and effectively. As the body’s tolerance to heroin falls during detox, the risk of accidental overdose on any relapse is dramatically elevated. Naloxone is freely available from drug treatment services, pharmacies, and needle exchange programmes across the UK and can be safely administered by anyone, including family members and friends, without medical training.
Carrying naloxone and knowing how to use it should be considered an essential component of safety planning for anyone in the detox and early recovery phase.
Heroin Detox at Banbury Lodge
At Banbury Lodge, we provide safe, compassionate, and clinically rigorous residential heroin detox. Our experienced team is dedicated to ensuring that withdrawal is managed as comfortably and safely as possible, while our therapeutic programme provides the psychological foundation for lasting recovery.
Our heroin detox programme includes:
- Nursing support throughout the withdrawal process
- Evidence-based medication protocols including opioid substitution tapering and symptomatic relief
- Concurrent psychological support to address distress arising during withdrawal
- Comprehensive psychiatric assessment and dual diagnosis care
- Nutritional restoration and holistic wellbeing support
- A structured pathway into our residential rehabilitation programme following completed detox
- Long-term aftercare planning to support sustained recovery beyond treatment
Heroin detox is one of the hardest things a person can face, but at Banbury Lodge, you will not face it alone. With the right clinical support and a treatment team that combines medical expertise with genuine human understanding, recovery from heroin addiction is within reach. If you or someone you love is ready to take the first step, contact us today.
Frequently asked questions
(Click here to see works cited)
- NHS (2024). Drug addiction: getting help. NHS.uk.
- National Institute on Drug Abuse (NIDA) (2022). Treatment Approaches for Drug Addiction DrugFacts. U.S. Department of Health and Human Services.
- Strang, J., et al. (2020). Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. British Journal of Psychiatry, 217(2), 504–512.
- World Health Organization (2009). Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. WHO.
- Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760–773.
- Kiefer, F., & Mann, K. (2010). Treating alcohol dependence after detoxification: why is it so difficult? Psychological Medicine, 40(11), 1817–1822.
- National Institute for Health and Care Excellence (NICE) (2007, updated 2021). Drug misuse in adults: CG51 and CG52. NICE.
- Public Health England (2020). Shooting Up: Infections among people who inject drugs in the UK. PHE Publications.
- Weiss, R. D., et al. (2011). Adjunctive Counselling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence. Archives of General Psychiatry, 68(12), 1238–1246.
- Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine, 374(4), 363–371.
- Amato, L., et al. (2011). Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database of Systematic Reviews, Issue 3.
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2023). Heroin and other opioids: Drug profile. EMCDDA.
